Norway Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017

Norway Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017

Summary

”Norway Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Norway Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Inhalation Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Inhalation Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market categories.
- Global corporate-level profiles of key companies operating within the Norway Drug Delivery Devicesmarket.
- Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Sunovion, Baxter International Inc., CareFusion Corporation and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Norway Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Drug Delivery Devices In Norway 10
3.1 Drug Delivery Devices, Norway, Overall Revenue ($m), 2003-2017 10
3.2 Drug Delivery Devices, Norway, Category Volume (Units), 2003-2017 16
3.3 Drug Delivery Devices, Norway, Company Share (2009-2010) 21
4 Central Venous Catheters In Norway 23
4.1 Central Venous Catheters Overall Revenue (2003-2017) 23
4.2 Central Venous Catheters Overall Volume (2003-2017) 26
4.3 Central Venous Catheters Average Price (2003-2017) 28
4.4 Central Venous Catheters Distribution Share (2009-2010) 29
4.5 Central Venous Catheters, Norway, Company Share (2009-2010) 30
5 Infusion Systems In Norway 32
5.1 Infusion Systems Overall Revenue (2003-2017) 32
5.1.1 Syringe Pumps Revenue (2003-2017) 36
5.1.2 Ambulatory Infusion Pumps Revenue (2003-2017) 39
5.2 Infusion Systems Overall Volume (2003-2017) 43
5.2.1 Syringe Pumps Volume (2003-2017) 47
5.2.2 Ambulatory Infusion Pumps Volume(2003-2017) 49
5.3 Infusion Systems Average Price (2003-2017) 52
5.4 Infusion Systems Distribution Share (2009-2010) 53
5.5 Infusion Systems, Norway, Company Share (2009-2010) 54
6 Metered Dose Inhaler Devices In Norway 56
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 56
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 58
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 60
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 61
6.5 Metered Dose Inhaler Devices, Norway, Company Share (2009-2010) 62
7 Needle Free Injections In Norway 63
7.1 Needle Free Injections Overall Revenue (2003-2017) 63
7.2 Needle Free Injections Overall Volume (2003-2017) 65
7.3 Needle Free Injections Average Price (2003-2017) 67
7.4 Needle Free Injections Distribution Share (2009-2010) 68
7.5 Needle Free Injections, Norway, Company Share (2009-2010) 69
8 Overview of Key Companies in Norway Drug Delivery Devices Market 70
8.1 GlaxoSmithKline plc 70
8.1.1 Company Overview 70
8.2 Boehringer Ingelheim GmbH 70
8.2.1 Company Overview 70
8.3 AstraZeneca PLC 70
8.3.1 Company Overview 70
8.4 Baxter International Inc. 71
8.4.1 Company Overview 71
8.5 CareFusion Corporation 71
8.5.1 Company Overview 71
8.6 Teleflex Incorporated 71
8.6.1 Company Overview 71
8.7 B. Braun Melsungen AG 72
8.7.1 Company Overview 72
8.8 Fresenius Kabi AG 72
8.8.1 Company Overview 72
8.9 Hospira, Inc. 72
8.9.1 Company Overview 72
8.10 Medtronic, Inc. 73
8.10.1 Company Overview 73
8.11 Terumo Corporation 73
8.11.1 Company Overview 73
8.12 Consort Medical plc 73
8.12.1 Company Overview 73
8.13 Smiths Medical 74
8.13.1 Company Overview 74
8.14 Becton, Dickinson and Company 74
8.14.1 Company Overview 74
8.15 Edwards Lifesciences Corporation 74
8.15.1 Company Overview 74
8.16 Codman & Shurtleff, Inc. 75
8.16.1 Company Overview 75
8.17 Cook Medical Incorporated 75
8.17.1 Company Overview 75
8.18 INJEX - Equidyne Systems 75
8.18.1 Company Overview 75
8.19 Antares Pharma, Inc. 76
8.19.1 Company Overview 76
8.20 Bioject Medical Technologies Inc. 76
8.20.1 Company Overview 76
9 Appendix 77
9.1 Global Markets Direct Research Methodology 77
9.2 Definitions of Markets Covered in the Report 78
9.2.1 Drug Delivery Devices 78
9.3 Secondary Research 80
9.4 Primary Research 81
9.5 Models 81
9.6 Forecasts 82
9.7 Expert Panel Validation 82
9.8 Currency Conversion 82
9.9 Contact Us 83
9.10 Disclaimer 83